Aftercare for childhood cancer survivors in Switzerland
Official title: Aftercare of Childhood Cancer Survivors in Switzerland - the ACCS Switzerland Project
Run by Kantonsspital Aarau · NCT04284189 · Data updated 2026-11-12
This study is trying to find out how childhood cancer survivors in Switzerland feel about their follow-up care as they transition from pediatric to adult healthcare, so they can improve support for them.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 140 (estimated) |
| Sponsor | Kantonsspital Aarau Academic / other |
| Locations | 3 sites (Aarau and 2 other locations) |
| Status | Recruiting |
| Started | February 12, 2019 |
| Main results expected | April 2025 |
| Study ends | August 2030 |
| Registry record updated | August 17, 2022 |
| Trial ID | NCT04284189 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 16 and older who are at least 5 years post-treatment for childhood cancer and currently in follow-up care.
✕Probably not a fit
Patients who have undergone surgery only without increased risk of late effects or those with severe cognitive impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Aftercare of Childhood Cancer Survivors in Switzerland (ACCS) study is a multicenter cohort investigation focused on the transition of follow-up care from pediatric oncology to adult care for adolescent and young adult survivors of childhood cancer. It aims to gather data on the preferences and expectations of these survivors regarding their follow-up care through questionnaires. The study addresses the critical need for effective transition strategies, as many survivors experience late effects from their treatment. By comparing different aftercare models, the study seeks to identify the best practices that meet the needs of these individuals.
Why it matters
Potential benefit: If successful, this study could improve the follow-up care and quality of life for childhood cancer survivors transitioning to adult care.
How similar studies have gone: While there have been studies on childhood cancer survivorship, this specific approach to comparing transition models is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 5-year survivor of childhood cancer * Diagnosis according to ICCC3 I-XII; Langerhans cell histiocytosis (LCH), Hemophagocytic lymphohistiocytosis (HLH) * Age at diagnosis \<18 years * Age at study ≥16 years * At study start in follow-up care at one of the three pediatric oncology centers (group before transition) or transitioned not before 2014 (group after transition). * Written informed consent Exclusion Criteria: * Treatment only by means of surgery and without increased risk of late effects (e.g. teratoma) * \<5 years after therapy of a relapse or palliative situation * Severe cognitive impairment, which makes it impossible to complete the questionnaire independently * Insufficient knowledge of the German language * Informed consent form not signed
Where it's running
-
Division of Oncology - Hematology, Department of Pediatrics, Kantonsspital Aarau
Aarau, Switzerland Recruiting -
Division of Oncology/ Hematology, University Children's Hospital Basel
Basel, Switzerland Recruiting -
Division of Oncology/ Hematology, Department of Pediatrics, Kantonsspital Lucerne
Lucerne, Switzerland Recruiting
Study contacts
- Principal investigator: Katrin Scheinemann, MD — Kantonsspital Aarau
- Study coordinator: Katrin Scheinemann, MD
- Email: katrin.scheinemann@ksa.ch
- Phone: 004162 838 4909
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cognitive training with real-time brain feedback for childhood medulloblastoma survivors
This study tests whether real-time brain feedback using rt-fMRI or rt-fNIRS can help children and young adults who survived childhood medulloblastoma improve attention and working memory.
-
Community-led, family-centered communication for Hispanic childhood cancer survivors
This study tests a family-focused communication approach to help young Hispanic adult survivors, their families, and clinicians talk more effectively about survivorship care.
-
Hematologic cancer survivors after stem cell transplant try a personalized care plan
This study tests a personalized Survivorship Care Plan for people with hematologic cancer who have undergone a stem cell transplant to see if it’s feasible within the Italian health system.
-
Support program to improve quality of life for Chinese cancer patients and survivors
This program will try different mixes of education, counseling, and peer support to see if they help Mandarin-speaking adults with cancer or who have finished treatment feel better.
-
Blood biomarkers for treatment-related brain injury in children with brain tumors
This project will test whether blood plasma biomarkers can show treatment-related brain injury in children with primary brain tumors by comparing those who receive radiotherapy, those who do not, and healthy children of the same age and sex.
-
On-Trac: Online training to manage anxiety after cancer
This program will try an online CBT- and ACT-based education plus brief coaching to help adult cancer survivors manage ongoing anxiety.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.